Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP015K and Metformin DDI Study
NCT02760342Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- May 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Primary endpoints: Pharmacokinetics parameter of metformin in plasma: AUCinf, Pharmacokinetics parameter of metformin in plasma: Cmax and 1 more. Started May 2016; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02760342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760342.